Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

321.6500 USD 1.2000 0.37%

As of 20:10:00 ET on 01/30/2015.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 323.9300 High - Low: 329.1600 - 321.0600 Primary Exchange: NASDAQ GM
Volume: 1,688,555 52-Week Range: 207.4800 - 329.1950 Beta vs XNBI: 1.0007

ETF Chart for IBB

No chart data available.
  • IBB:US 321.3300
  • 1D
  • 1M
  • 1Y
322.8500
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / RENE CASIS
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2015-01-30) 321.5000
Assets (M) (on 2015-01-30) 7,362.4450
Shares out (M) 22.90
Market Cap (M) 7,365.78
% Premium 0.05
Average 52-Week % Premium 0.0093
Fund Leveraged N

Dividends for IBB

Dividend Type Omitted
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.14%

Performance for IBB

1-Month +6.03% 1-Year +31.03%
3-Month +8.44% 3-Year +40.81%
Year To Date +6.03% 5-Year +31.33%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 01/29/2015
Name Position Value % of Total
Biogen Idec Inc 1,805,362 637,744,127 8.724%
Celgene Corp 4,886,022 590,573,479 8.079%
Gilead Sciences Inc 5,537,201 576,865,600 7.891%
Amgen Inc 3,360,309 525,451,518 7.188%
Regeneron Pharmaceuticals Inc 1,114,654 462,180,135 6.322%
Illumina Inc 1,455,035 291,007,000 3.981%
Vertex Pharmaceuticals Inc 2,356,212 268,938,038 3.679%
Alexion Pharmaceuticals Inc 1,425,095 267,989,115 3.666%
Mylan Inc/PA 4,470,626 245,370,308 3.356%
BioMarin Pharmaceutical Inc 1,761,472 175,530,685 2.401%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil